BR9912266A - Derovados da 6-desóxi eritromicina, processo de preparação dos mesmos e aplicação dos mesmos como medicamentos - Google Patents

Derovados da 6-desóxi eritromicina, processo de preparação dos mesmos e aplicação dos mesmos como medicamentos

Info

Publication number
BR9912266A
BR9912266A BR9912266-9A BR9912266A BR9912266A BR 9912266 A BR9912266 A BR 9912266A BR 9912266 A BR9912266 A BR 9912266A BR 9912266 A BR9912266 A BR 9912266A
Authority
BR
Brazil
Prior art keywords
same
medicines
derived
application
preparation process
Prior art date
Application number
BR9912266-9A
Other languages
English (en)
Other versions
BRPI9912266B8 (pt
BR9912266B1 (pt
Inventor
Jean-Michel Auger
Alexis Denis
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR9912266A publication Critical patent/BR9912266A/pt
Publication of BR9912266B1 publication Critical patent/BR9912266B1/pt
Publication of BRPI9912266B8 publication Critical patent/BRPI9912266B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DA 6-DESóXI ERITROMICINA, PROCESSO DE PREPARAçãO DOS MESMOS E APLICAçãO DOS MESMOS COMO MEDICAMENTOS"<D>. A invenção tem por objetivo os compostos de fórmula (I) nos quais: X representa um radical (NH)a, CH~ 2~ ou SO~ 2~ ou um átomo de oxigênio, a representa o número 0 ou 1, Y representa um radical (CH~ 2~)m-(CH=CH) n-(CH~ 2~)o com m+n+o <243> 8, n = 0 ou 1, Ar representa um radical arila ou heteroarila, eventualmente substituído, W representa um átomo de hidrogênio ou um átomo de halogênio, Z representa um átomo de hidrogênio ou o resto de um ácido assim como sais de adição do mesmo com os ácidos. Os compostos de fórmula (I) apresentam propriedades antibióticas.
BRPI9912266A 1998-07-21 1999-07-20 composto derivado da 6-desóxi eritromicina, bem como medicamentos e composições farmacêuticas contendo os mesmos. BRPI9912266B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9809259A FR2781484B1 (fr) 1998-07-21 1998-07-21 Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1999/001769 WO2000005239A1 (fr) 1998-07-21 1999-07-20 Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
BR9912266A true BR9912266A (pt) 2001-04-17
BR9912266B1 BR9912266B1 (pt) 2013-05-14
BRPI9912266B8 BRPI9912266B8 (pt) 2021-05-25

Family

ID=9528813

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9912266A BRPI9912266B8 (pt) 1998-07-21 1999-07-20 composto derivado da 6-desóxi eritromicina, bem como medicamentos e composições farmacêuticas contendo os mesmos.

Country Status (23)

Country Link
US (1) US6706692B1 (pt)
EP (1) EP1098901B1 (pt)
JP (1) JP4583601B2 (pt)
KR (1) KR20010071993A (pt)
CN (1) CN1359386A (pt)
AT (1) ATE231161T1 (pt)
AU (1) AU761551B2 (pt)
BR (1) BRPI9912266B8 (pt)
CA (1) CA2338172C (pt)
CZ (1) CZ2001237A3 (pt)
DE (1) DE69904940T2 (pt)
DK (1) DK1098901T3 (pt)
EA (1) EA003776B1 (pt)
ES (1) ES2188193T3 (pt)
FR (1) FR2781484B1 (pt)
HU (1) HUP0103997A3 (pt)
IL (1) IL140976A0 (pt)
MX (1) MXPA01000559A (pt)
NO (1) NO20010332L (pt)
PT (1) PT1098901E (pt)
TR (1) TR200100178T2 (pt)
WO (1) WO2000005239A1 (pt)
ZA (1) ZA200100566B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340183T1 (de) * 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
IL126624A0 (en) * 1996-05-07 1999-08-17 Abbott Lab 3-descladinose-2, 3-anhydroerythromycin derivatives
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO2000062783A2 (en) * 1999-04-16 2000-10-26 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials

Also Published As

Publication number Publication date
CZ2001237A3 (cs) 2001-10-17
MXPA01000559A (es) 2002-04-08
FR2781484A1 (fr) 2000-01-28
NO20010332D0 (no) 2001-01-19
TR200100178T2 (tr) 2002-10-21
NO20010332L (no) 2001-03-20
JP2003534231A (ja) 2003-11-18
BRPI9912266B8 (pt) 2021-05-25
ZA200100566B (en) 2002-12-24
DE69904940D1 (de) 2003-02-20
ES2188193T3 (es) 2003-06-16
US6706692B1 (en) 2004-03-16
EA200100163A1 (ru) 2001-08-27
BR9912266B1 (pt) 2013-05-14
CA2338172A1 (fr) 2000-02-03
WO2000005239A1 (fr) 2000-02-03
JP4583601B2 (ja) 2010-11-17
CN1359386A (zh) 2002-07-17
FR2781484B1 (fr) 2001-08-10
IL140976A0 (en) 2002-02-10
DE69904940T2 (de) 2003-08-28
HUP0103997A2 (hu) 2002-02-28
ATE231161T1 (de) 2003-02-15
KR20010071993A (ko) 2001-07-31
PT1098901E (pt) 2003-06-30
DK1098901T3 (da) 2003-05-05
HU0103997D0 (en) 2001-11-28
HUP0103997A3 (en) 2003-11-28
EA003776B1 (ru) 2003-08-28
EP1098901A1 (fr) 2001-05-16
AU761551B2 (en) 2003-06-05
EP1098901B1 (fr) 2003-01-15
AU4913299A (en) 2000-02-14
CA2338172C (fr) 2010-09-07

Similar Documents

Publication Publication Date Title
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
BRPI0111596B8 (pt) Composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto
BR0214485A (pt) 3-cianoquinolinas como inibidores de egf-r e her2 quinases
TR200003632T2 (tr) Benzotiyepin-1,1-dioksid türevleri, üretim yöntemi, bunları içeren ilaçlar.
BR0016543A (pt) Novos derivados de piperidina e piperazina
BR0001468A (pt) ácidos dioxiciclopentil hidroxânicos
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
BRPI9914221B8 (pt) derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
CO5210911A1 (es) Trifluorbutenos nematicidas
RS41104A (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
NO333251B1 (no) Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
HUP0500478A2 (hu) Taxánszármazékokat tartalmazó tumorellenes készítmények
BR0212069A (pt) Agentes antidiabéticos orais
BR0012032A (pt) Derivado do grupo a de estreptograminas, processo de preparação do mesmo, e composição farmacêutica
CY1105550T1 (el) Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
BR9912266A (pt) Derovados da 6-desóxi eritromicina, processo de preparação dos mesmos e aplicação dos mesmos como medicamentos
BR0012736A (pt) Processo para a preparação de pirimidinas substituìdas, e, composto
BR9807795A (pt) Derivados da eritromicina, seu processo de preparo e sua aplicação como medicamentos
BRPI9710537B8 (pt) derivados da eritromicina, composições farmacêuticas, bem como processo para preparação dos mesmos.
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
BR9714007A (pt) Novos derivados da eritromicina seu processo de preparação e sua aplicação como medicamentos
BR0000901A (pt) Derivados 4-fenil-4-heteroarilpiperidina

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/05/2013, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/07/1999 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 20/07/2019